TickerFacts.

Volitionrx Ltd (VNRX): Long-Term Debt

Annual figures by period end, from SEC filings.

$6.71M
As of 2025-12-31
$7.05M
As of 2026-06-30
+20.4%
3-year compound annual growth
+14.2%
5-year compound annual growth
n/m
10-year compound annual growth
2015-12-31: $20.4K2016-12-31: $162.4K2017-12-31: -$157.5K2018-12-31: $2.40M2019-12-31: $2.84M2020-12-31: $3.45M2021-12-31: $3.07M2022-12-31: $3.85M2023-12-31: $4.83M2024-12-31: $4.81M2025-12-31: $6.71M$6.71M
2015-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$6.71M+39.4%2026-03-31, Balance as of period end
2024-12-31$4.81M-0.4%2025-03-31, Balance as of period end
2023-12-31$4.83M+25.6%2024-03-25, Balance as of period end
2022-12-31$3.85M+25.3%2023-03-15, Balance as of period end
2021-12-31$3.07M-11.0%2022-03-30, Balance as of period end
2020-12-31$3.45M+21.3%2021-03-22, Balance as of period end
2019-12-31$2.84M+18.4%2020-02-20, Balance as of period end
2018-12-31$2.40Mn/m2019-03-13, Balance as of period end
2017-12-31-$157.5Kn/m2018-03-01, Balance as of period end
2016-12-31$162.4K+697.5%2017-03-10, Balance as of period end
2015-12-31$20.4Kn/a2016-03-11, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Volitionrx Ltd (VNRX)2025-12-31$6.71M+39.4%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.28M-15.3%
Immucell Corp (ICCC)2025-12-31$9.10Mn/a
Alpha Teknova, Inc. (TKNO)2025-12-31$13.12M+39.0%
Myriad Genetics Inc (MYGN)2025-12-31$119.90Mn/a
QuidelOrtho Corp (QDEL)2025-12-28$2.70B+8.4%
Idexx Laboratories Inc (IDXX)2025-12-31$450.00M-27.2%

Compare VNRX, AWHL, ICCC, TKNO side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗